1237 related articles for article (PubMed ID: 33762954)
21. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening.
Dehelean CA; Lazureanu V; Coricovac D; Mioc M; Oancea R; Marcovici I; Pinzaru I; Soica C; Tsatsakis AM; Cretu O
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32630746
[TBL] [Abstract][Full Text] [Related]
22. Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic.
Mir I; Aamir S; Shah SRH; Shahid M; Amin I; Afzal S; Nawaz A; Khan MU; Idrees M
Osong Public Health Res Perspect; 2022 Apr; 13(2):84-100. PubMed ID: 35538681
[TBL] [Abstract][Full Text] [Related]
23. Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquine.
Wüstner S; Hogger S; Gartner-Freyer D; Lebioda A; Schley K; Leverkus F
Front Public Health; 2022; 10():804404. PubMed ID: 35252090
[TBL] [Abstract][Full Text] [Related]
24. Drug repurposing in COVID-19: A review with past, present and future.
Srivastava K; Singh MK
Metabol Open; 2021 Dec; 12():100121. PubMed ID: 34462734
[TBL] [Abstract][Full Text] [Related]
25. Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review.
Lem FF; Opook F; Lee DJH; Chee FT; Lawson FP; Chin SN
Front Pharmacol; 2020; 11():585331. PubMed ID: 33746739
[No Abstract] [Full Text] [Related]
26. Antiviral Therapeutic Approaches for SARS-CoV-2 Infection: A Systematic Review.
Gil Martínez V; Avedillo Salas A; Santander Ballestín S
Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451833
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review.
Velásquez PA; Hernandez JC; Galeano E; Hincapié-García J; Rugeles MT; Zapata-Builes W
Clin Pharmacol; 2024; 16():1-25. PubMed ID: 38197085
[TBL] [Abstract][Full Text] [Related]
28. Present and future treatment strategies for coronavirus disease 2019.
Elekhnawy E; Kamar AA; Sonbol F
Futur J Pharm Sci; 2021; 7(1):84. PubMed ID: 33850936
[TBL] [Abstract][Full Text] [Related]
29. Scoping insight on antiviral drugs against COVID-19.
Ali AS; Ibrahim IM; Burzangi AS; Ghoneim RH; Aljohani HS; Alsamhan HA; Barakat J
Arab J Chem; 2021 Oct; 14(10):103385. PubMed ID: 34909060
[TBL] [Abstract][Full Text] [Related]
30. Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies.
Baburaj G; Thomas L; Rao M
Arch Med Res; 2021 Apr; 52(3):261-269. PubMed ID: 33257051
[TBL] [Abstract][Full Text] [Related]
31. Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector.
Dube T; Ghosh A; Mishra J; Kompella UB; Panda JJ
Adv Ther (Weinh); 2021 Feb; 4(2):2000172. PubMed ID: 33173808
[TBL] [Abstract][Full Text] [Related]
32. A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges.
Hossen MS; Barek MA; Jahan N; Safiqul Islam M
SN Compr Clin Med; 2020; 2(10):1777-1789. PubMed ID: 32904710
[TBL] [Abstract][Full Text] [Related]
33. Antivirals for COVID-19.
Srinivas P; Sacha GL; Koval C
Cleve Clin J Med; 2020 Oct; ():. PubMed ID: 32409433
[TBL] [Abstract][Full Text] [Related]
34. Pandemic COVID-19: Current status and challenges of antiviral therapies.
Chan W; He B; Wang X; He ML
Genes Dis; 2020 Dec; 7(4):502-519. PubMed ID: 32837984
[TBL] [Abstract][Full Text] [Related]
35. SAR based Review on Diverse Heterocyclic Compounds with Various Potential Molecular Targets in the Fight against COVID-19: A Medicinal Chemist Perspective.
Madan A; Garg M; Satija G; Sharma B; Shaquiquzzaman M; Akhter M; Iqubal A; Khan MA; Parvez S; Das A; Sheikh KA; Alam MM
Curr Top Med Chem; 2023; 23(14):1319-1339. PubMed ID: 36703601
[TBL] [Abstract][Full Text] [Related]
36. Review of investigational drugs for coronavirus disease 2019.
Sharma D; Sharma N; Sharma P; Subramaniam G
J Educ Health Promot; 2021; 10():31. PubMed ID: 33688540
[TBL] [Abstract][Full Text] [Related]
37. Determining similarities of COVID-19 - lung cancer drugs and affinity binding mode analysis by graph neural network-based GEFA method.
Budak C; Mençik V; Gider V
J Biomol Struct Dyn; 2023 Feb; 41(2):659-671. PubMed ID: 34877907
[TBL] [Abstract][Full Text] [Related]
38. Drugs intervention study in COVID-19 management.
Taher M; Tik N; Susanti D
Drug Metab Pers Ther; 2021 Apr; ():. PubMed ID: 33818031
[TBL] [Abstract][Full Text] [Related]
39. Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives.
Vivekanandhan K; Shanmugam P; Barabadi H; Arumugam V; Daniel Raj Daniel Paul Raj D; Sivasubramanian M; Ramasamy S; Anand K; Boomi P; Chandrasekaran B; Arokiyaraj S; Saravanan M
Front Mol Biosci; 2021; 8():604447. PubMed ID: 33763450
[TBL] [Abstract][Full Text] [Related]
40. Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic.
Vallianou NG; Tsilingiris D; Christodoulatos GS; Karampela I; Dalamaga M
Metabol Open; 2021 Jun; 10():100096. PubMed ID: 34056571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
